Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine Alifrangis

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Future Oncology (London, England)|June 1, 2014
The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancyJustin Stebbing, Victoria Harding, Catherine E Urch, et al.
Frontiers in Oncology|November 13, 2023
Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapyGeorgina E Wood, Christopher P Bunting, Mesel Veli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR InhibitionJosine M Quispel-Janssen, Jitendra Badhai, Laurel Schunselaar, et al.
BJU International|May 11, 2023
Outcomes of penile sarcomatoid squamous cell carcinoma from a single tertiary referral centre: a matched cohort studyKarl H Pang, Benedict Girling, Elizabeth Osinibi, et al.
Pigment Cell & Melanoma Research|September 16, 2018
A lentiviral vector-based insertional mutagenesis screen identifies mechanisms of resistance to MAPK inhibitors in melanomaMarco Ranzani, Constantine Alifrangis, Nicola A Thompson, et al.
British Journal of Cancer|September 29, 2020
The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)Jonathan Shamash, Wendy Ansell, Constantine Alifrangis, et al.
International Journal of Impotence Research|February 29, 2024
Long-term outcomes of penile squamous cell carcinoma in men age ≤50 years old compared with men >50 years old from a single tertiary referral centre: a propensity score matched analysisKarl H Pang, Giuseppe Fallara, Morwarid Hemat, et al.
Pigment Cell & Melanoma Research|September 23, 2014
BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinibMarco Ranzani, Constantine Alifrangis, Daniele Perna, et al.
BJU International|August 20, 2022
Management of small testicular masses: outcomes from a single-centre specialist multidisciplinary teamShafi Wardak, Karl H Pang, Fabio Castiglione, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2020
Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patientsConstantine Alifrangis, Anand Sharma, Shafi Chowdhury, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Future Oncology (London, England)|June 1, 2014
The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancyJustin Stebbing, Victoria Harding, Catherine E Urch, et al.
Frontiers in Oncology|November 13, 2023
Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapyGeorgina E Wood, Christopher P Bunting, Mesel Veli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR InhibitionJosine M Quispel-Janssen, Jitendra Badhai, Laurel Schunselaar, et al.
BJU International|May 11, 2023
Outcomes of penile sarcomatoid squamous cell carcinoma from a single tertiary referral centre: a matched cohort studyKarl H Pang, Benedict Girling, Elizabeth Osinibi, et al.
Pigment Cell & Melanoma Research|September 16, 2018
A lentiviral vector-based insertional mutagenesis screen identifies mechanisms of resistance to MAPK inhibitors in melanomaMarco Ranzani, Constantine Alifrangis, Nicola A Thompson, et al.
British Journal of Cancer|September 29, 2020
The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)Jonathan Shamash, Wendy Ansell, Constantine Alifrangis, et al.
International Journal of Impotence Research|February 29, 2024
Long-term outcomes of penile squamous cell carcinoma in men age ≤50 years old compared with men >50 years old from a single tertiary referral centre: a propensity score matched analysisKarl H Pang, Giuseppe Fallara, Morwarid Hemat, et al.
Pigment Cell & Melanoma Research|September 23, 2014
BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinibMarco Ranzani, Constantine Alifrangis, Daniele Perna, et al.
BJU International|August 20, 2022
Management of small testicular masses: outcomes from a single-centre specialist multidisciplinary teamShafi Wardak, Karl H Pang, Fabio Castiglione, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2020
Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patientsConstantine Alifrangis, Anand Sharma, Shafi Chowdhury, et al.
Pageof 6